Structure Therapeutics Inc.

12/17/2024 | Press release | Distributed by Public on 12/17/2024 15:01

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity